Based on IMS Wellness data, direction drug sales in the United States grew 12% in 2002.
Yet, when asking medical specialty directors at eudaimonia plans or PBMs how much direction drug costs will step-up in 2003, it seems the solution, without much belief or consideration, is 15% to 20%.
Maybe we’ve gotten so used to quoting this digit because it’s been the approximate way rate for most plans over the past few long time that we forget that this year may be different.
According to results of a Managed Healthcare Mercantile establishment Making known looking at published in their October 31, 2002, newsletter, most John Major HMOs expect to see continued tendency rates on written language drugs of 15% to 20% through 2003.
Fewer plans surveyed stated they expect tendency rates to moderate in 2003, with rates somebody to 10% to 15%.
As a upshot, plans have raised premiums and copays, highlighting to employers and others the continued relative of out-of-control drug expenditures.
In thinking about last year’s way rate of 12% and the changes that have occurred in 2002, it’s hard for me to imagine how we could have another 20% drift year in 2003.
IMS analysts expect 2003 to be a 10% to 11% maturation year.
There are 3 reasons for this more modest expulsion.
Point, in 2002, the FDA approved the fewest size of new drug applications since 1983, with only 17 new molecular entities (NMEs) approved, down from 24 in 2001 and 27 in 2000.
The 17 agents approved last year are only a bag of the all-time high of 53 NMEs approved in 1996.
Time, 2002 saw the most instrument expirations ever in a bingle year with 79 first-time generics beingness approved, including metformin, amoxicillin/clavulanate, lisinopril, and omeprazole.
Finally, Claritin became available OTC, activity many plans to thing their reportage policies and slope copays signigicantly for the remaining written language nonsedating antihistamine agents.
This is a part of article Will Pharmacy Benefit Costs Really Jump Another 20% This Year? Taken from "Generic Claritin (Loratadine)" Information Blog
Sunday, October 28, 2007
Will Pharmacy Benefit Costs Really Jump Another 20% This Year?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment